Cite

HARVARD Citation

    , . et al. (2018). Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial. Lancet. 5 (10), pp. e553-e559. [Online]. 
  
Back to record